查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519749

2024-2032 年合成生物学市场报告（按产品、技术、应用和地区）

Synthetic Biology Market Report by Product, Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球合成生物学市场规模达160亿美元。基因编辑技术的显着进步、跨行业可持续解决方案的需求不断增长、协作生态系统以及风险资本投资的增加是推动市场的一些主要因素。

合成生物市场分析：

主要市场驱动因素：在基因编辑技术不断进步的推动下，全球合成生物学市场正经历强劲成长。

主要市场趋势：学术界、工业界和政府之间的合作正在增强创新和发展能力。

地理趋势：由于生技投资不断增加，北美在市场上占据主导地位。然而，由于该地区研究活动和政府措施的不断增加，亚太地区正在成为一个快速成长的市场。

竞争格局：主要参与者正在投资研究业务，以推动创新并应对复杂的生物挑战。合成生物学产业的一些主要市场参与者包括 GenScript Biotech Corporation、Amyris Inc.、Ginkgo Bioworks、Mammoth Biosciences、Novozymes、Merck KGaA 等。

挑战与机会：挑战包括与基因改造产品相关的道德和安全问题。儘管如此，市场开发符合监管、道德考虑的创新的机会预计将克服这些挑战。

合成生物学市场趋势/驱动因素：

基因编辑技术的进步

目前，CRISPR-Cas9等各种技术能够透过精确有效地操作遗传物质来改善生物学研究领域，增强合成生物学市场需求。研究人员正在以极高的精度设计、编辑和改造 DNA 序列，从而促进根据特定功能定制的复杂合成生物体的创建。这项创新为新方面的发展开闢了新途径，例如透过基因疗法治疗疾病，以及创造能够生产酵素和生物燃料等有价值化合物的生物工程生物体，从而有助于市场扩张。此外，世界卫生组织（WHO）发布了人类基因组编辑全球治理的开创性建议，强调安全性、有效性和伦理。

对永续解决方案的需求

各行业对永续和环保解决方案的需求不断增长，正在推动合成生物学市场的发展。合成生物学为各行业提供了各种新途径来满足其减少营运对环境影响的需求。据此，从再生资源中提取的生物塑胶的生产以及减少碳排放的生物燃料的开发与全球推动永续发展相一致，正在促进市场成长。除此之外，合成生物学能够创造用于生物修復的微生物，这是一种解毒污染物或帮助净化环境并解决各种紧急生态併发症的方法。此外，合成生物学正在彻底改变美容产业的永续发展努力。 Vogue Business 估计，每年有 20-40% 的美容产品变成废物，该行业每年产生 1200 亿个难以回收的包装。此外，十分之八的化妆品成分来源并不可持续。为了应对这些挑战，合成生物学会修改微生物 DNA 以创造永续材料。合成生物学市场价格反映出由于创新和多样化应用而快速成长。

协作生态系统与投资

学术界、工业界和政府实体之间的协作为合成生物学领域的研究运作创造了有利的环境。合作促进了知识、资产和观点的交流，从而加快了发明的速度。管理当局经常提供赠款和资金来协助研究工作，而老牌企业和新创公司则共同努力，为促进市场成长的突破性企业汇集资源。除此之外，对生技新创公司的创投激增为该领域注入了重要资本，培育了新兴创意朝向有形产品和合成生物学市场应用的发展。这个协作生态系统维持研究、创新和商业化的循环，推动全球合成生物学市场向前发展。

此外，合成生物学市场的未来有望带来无与伦比的创新、永续解决方案和广泛的成长潜力。 Algal Bio 等公司利用多种菌株来创新新颖的解决方案，而 Basecamp Research 等新创公司则利用机器学习 (ML) 来破解合成蛋白质工程的自然设计原理。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球合成生物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 寡核苷酸/寡核苷酸库和合成 DNA
    • 市场走向
    • 市场预测
  • 酵素
    • 市场走向
    • 市场预测
  • 克隆技术套件
    • 市场走向
    • 市场预测
  • 异种核酸
    • 市场走向
    • 市场预测
  • 底盘机构
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 新一代定序技术
    • 市场走向
    • 市场预测
  • PCR技术
    • 市场走向
    • 市场预测
  • 基因组编辑技术
    • 市场走向
    • 市场预测
  • 生物加工技术
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 卫生保健
    • 市场走向
    • 关键环节
      • 临床
      • 非临床/研究
    • 市场预测
  • 非医疗保健
    • 市场走向
    • 关键环节
      • 生物技术作物
      • 特种化学品
      • 生物燃料
      • 其他的
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Amyris Inc.
    • Codexis Inc.
    • Danaher Corporation
    • Eurofins Scientific
    • GenScript Biotech Corporation
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs
    • Synthego Corporation
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • Viridos Inc.
Product Code: SR112024A5534

The global synthetic biology market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 62.0 Billion by 2032, exhibiting a growth rate (CAGR) of 15.9% during 2024-2032. Significant advancements in gene editing technologies, the rising demand for sustainable solutions across industries, collaborative ecosystems, and increasing venture capital investments are some of the major factors propelling the market.

Synthetic Biology Market Analysis:

Major Market Drivers: The global synthetic biology market is experiencing robust growth, driven by increasing improvements in gene editing technologies.

Key Market Trends: Collaborative efforts between academia, industry, and government are enhancing innovation and development capabilities.

Geographical Trends: North America dominates the market owing to the growing investments in biotechnology. However, Asia Pacific is emerging as a fast-growing market due to the increasing research activities and government initiatives in the region.

Competitive Landscape: Key players are investing in research operations to drive innovation and address complex biological challenges. Some of the major market players in the synthetic biology industry include GenScript Biotech Corporation, Amyris Inc., Ginkgo Bioworks, Mammoth Biosciences, Novozymes, Merck KGaA, among many others.

Challenges and Opportunities: Challenges include ethical and safety concerns related to genetically modified products. Nonetheless, opportunities for the market to develop regulatory-compliant, ethically considered innovations are projected to overcome these challenges.

Synthetic Biology Market Trends/Drivers:

Advancements in gene editing technologies

At present, various techniques like CRISPR-Cas9 are capable of improving the field of biology research by enabling precise and efficient manipulation of genetic material, strengthening the synthetic biology market demand. Researchers are designing, editing, and engineering DNA sequences with exceptional accuracy, facilitating the creation of intricate synthetic organisms customized according to specific functions. This innovation is opening new avenues for the development of novel aspects, like disease treatment through gene therapies and creation of bioengineered organisms capable of producing valuable compounds such as enzymes and biofuels, thus aiding in market expansion. Moreover, The World Health Organization (WHO) released groundbreaking recommendations for the global governance of human genome editing, emphasizing safety, efficacy, and ethics.

Demand for sustainable solutions

The rising demand for sustainable and environment-friendly solutions across various industries is propelling the synthetic biology market. Synthetic biology presents various new avenues for sectors to fulfill their demands to reduce the environmental impact of their operations. In line with this, the production of bioplastics extracted from renewable resources and the development of biofuels with reduced carbon emissions aligning with the global push towards sustainability are contributing to the market growth. Apart from this, synthetic biology is capable of creating microbes for bioremediation which is a method to detoxify contaminants or help clean up the environment and address various urgent ecological complications. Furthermore, synthetic biology is revolutionizing the sustainability efforts of the beauty sector. Vogue Business estimates that 20-40% of beauty products become waste annually, and the industry generates 120 billion units of difficult-to-recycle packaging yearly. Moreover, eight out of ten cosmetic ingredients are unsustainably sourced. To address these challenges, synthetic biology modifies microorganism DNA to create sustainable materials. The synthetic biology market price reflects rapid growth due to innovation and diverse applications.

Collaborative ecosystem and investment

The collaborative synergy between academia, industry, and government entities fosters a conducive environment for research operations within the synthetic biology field. Collaborations facilitate the exchange of knowledge, assets, and perspectives, thus quickening the rate of invention. Governing authorities frequently provide grants and funds to assist research endeavors, while established businesses and startups work together to pool resources for ground-breaking ventures that promote market growth. In addition to this, the surge in venture capital investments in biotechnology startups injects vital capital into the field, nurturing the growth of nascent ideas into tangible products and synthetic biology market application. This collaborative ecosystem sustains a cycle of research, innovation, and commercialization, propelling the global synthetic biology market forward.

Additionally, the future of the synthetic biology market promises unparalleled innovation, sustainability solutions, and expansive growth potential. Companies, such as Algal Bio utilize a diverse array of strains to innovate novel solutions, while startups like Basecamp Research employ machine learning (ML) to decipher the design principles of nature for synthetic protein engineering.

Synthetic Biology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global synthetic biology market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, and application.

Breakup by Product:

Oligonucleotide/Oligo Pools and Synthetic DNA

Enzymes

Cloning Technologies Kits

Xeno-nucleic Acids

Chassis Organism

Oligonucleotide/oligo pools and synthetic DNA dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes oligonucleotide/oligo pools and synthetic DNA, enzymes, cloning technologies kits, Xeno-nucleic acids, and chassis organism. According to the report, oligonucleotide/oligo pools and synthetic DNA represented the largest segment.

The growing demand for synthetic biology products, specifically oligonucleotide/oligo pools and synthetic DNA, is mainly fueled by the exponential growth in fields such as personalized medicine, gene therapy, and molecular diagnostics that have amplified the need for precise and customizable genetic materials. Additionally, the rise of synthetic biology startups and the democratization of gene editing technologies have made these products more accessible, empowering researchers across diverse disciplines to engage in innovative projects, thereby creating a favorable synthetic biology market outlook. For example, Synbio Technologies offers oligo pool synthesis for companies or clients who need to mass-produce short DNA strands, also known as oligonucleotides.

Breakup by Technology:

NGS Technology

PCR Technology

Genome Editing Technology

Bioprocessing Technology

Others

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes NGS, PCR, genome editing, bioprocessing, and other technologies.

Next-generation sequencing (NGS) technology has become instrumental in deciphering complex biological information, facilitating the analysis of vast genetic data sets, and accelerating the discovery of novel genetic components, which in turn, is presenting lucrative market opportunities. Moreover, polymerase chain reaction (PCR) technology remains a cornerstone for DNA amplification, crucial in generating sufficient genetic material for various applications, from research to diagnostics. Besides this, genome editing technologies, particularly CRISPR-Cas9, hold immense promise for precision genetic modifications, driving advancements in gene therapies and customized genetic engineering. Bioprocessing technologies form a critical facet, enabling efficient large-scale production of bioengineered compounds, ranging from pharmaceuticals to biofuels. Companies are also investing and focusing on these aspects to create novel technologies. For example, Bayer and Mammoth Biosciences collaborated to develop a novel gene editing technology to unlock the full potential of CRISPR systems.

Additionally, the synthetic biology market statistics highlight a robust growth trajectory, driven by advancements in biotechnology and increasing investment in research and development.

Breakup by Application:

Healthcare

Clinical

Non-Clinical/Research

Non-Healthcare

Biotech Crops

Specialty Chemicals

Bio-Fuels

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes healthcare (clinical and non-clinical/research) and non-healthcare (biotech crops, specialty chemicals, bio-fuels, and others).

The bolstering growth of the healthcare sector, wherein synthetic biology is used in the development of personalized medicines, gene therapies, and diagnostics, is contributing to the synthetic biology market growth. In addition, the numerous non-clinical or research applications of synthetic biology encompassing drug discovery, functional genomics, and biomolecule production, are fueling scientific exploration and market growth. Beyond healthcare, synthetic biology's expanding usage in biotech crops engineered for improved yield and resistance to pests is positively influencing the market. Furthermore, the increasing product adoption across the specialty chemicals industry, wherein bioengineered pathways create sustainable routes to produce high-value compounds is impelling the market growth. Apart from this, the growing use of synthetic biology in the biofuel sector to optimize microorganisms for efficient biofuel production is strengthening the market growth. Key market players are focusing on collaborating with each other to develop various novel technologies in synthetic biology. For instance, scientists led by Gerard Wright at McMaster University developed a synthetic biology platform for novel glycopeptide antibiotics (GPA) discovery. They engineered Streptomyces coelicolor as a chassis for GPA biosynthesis, overcoming challenges in cloning large biosynthetic gene clusters (BGCs) using an optimized transformation-associated recombination (TAR) system. The platform enabled the synthesis of corbomycin and the discovery of novel GPAs, expanding antibiotic candidates' repertoire.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest synthetic biology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The presence of a well-established research and innovation ecosystem in North America, characterized by leading academic institutions, cutting-edge biotechnology companies, and significant government investments, provides a fertile ground for advancements in synthetic biology. Moreover, the region's emphasis on R&D and technological innovation fosters collaborations that span academia and industry, driving the development of novel applications across sectors including healthcare, agriculture, and energy. In addition to this, the increasing focus on sustainable solutions and the demand for eco-friendly products align with synthetic biology's potential to offer greener alternatives. This, coupled with favorable regulatory frameworks that encourage biotechnology R&D, creates an environment conducive to the expansion of the North American synthetic biology market. In December 2022, the Investment Strategy by the Office of Strategic Capital (OSC) identifies synthetic biology as a priority technology area for private sector investment, aiming to attract capital and foster innovation in this field for national security purposes. The synthetic biology market overview reveals its rapid expansion, driven by innovation, research investment, and diverse applications.

Competitive Landscape:

The global synthetic biology market features a dynamic competitive landscape shaped by a blend of established players and innovative startups. Leading companies, with their significant financial resources and expansive research capabilities, dominate the market by offering a diverse range of synthetic biology products and services and highlighting how big is the synthetic biology market? These companies actively engage in collaborations, strategic partnerships, and mergers to enhance their offerings and expand their market reach. Furthermore, a surge in venture capital investments has catalyzed the emergence of agile startups, injecting fresh ideas and disruptive technologies into the field. The competitive arena is characterized by a focus on innovation, technology integration, and the ability to address diverse market segments, accentuating the evolutionary nature of the global synthetic biology market. On of the key players, Eurofins Genomics Blue Heron, introduced its IVT mRNA Synthesis Service, using cutting-edge technology for rapid and efficient mRNA transcript production. Tailored for various fields including molecular biology and gene therapy, it offers customizable synthesis with quick turnaround times and expert support, benefiting synthetic biology research and applications. According to synthetic biology market recent news, Aanika Biosciences is revolutionizing synthetic biology adoption across industries like food and agriculture through insurance. Their subsidiary, Aanika Insurance Services (AIS), offers cost-effective coverage, encouraging biologic use while ensuring risk mitigation and frequent sampling. Partnering with Western Growers Insurance Services, Aanika aims to expand its reach to farmers, distributors, and retailers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Amyris Inc.

Codexis Inc.

Danaher Corporation

Eurofins Scientific

GenScript Biotech Corporation

Illumina Inc.

Merck KGaA

New England Biolabs

Synthego Corporation

Thermo Fisher Scientific Inc.

Twist Bioscience

Viridos Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In May 2023, GenScript Biotech Corporation launched GenTitan(TM) Gene Fragments synthesis service, a commercial miniature semiconductor platform that utilizes integrated circuits for high-throughput DNA synthesis.

In May 2023, Codexis, Inc. unveiled Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis(TM) technology, a proprietary new synthesis platform being developed for manufacturing RNA oligonucleotide therapeutics at scale.

In January 2023, Agilent Technologies partnered with Akoya Biosciences to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the clinical research market.

Key Questions Answered in This Report:

  • How has the global synthetic biology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global synthetic biology market?
  • What is the impact of each driver, restraint, and opportunity on the global synthetic biology market?
  • What are the key regional markets?
  • Which countries represent the most attractive synthetic biology market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the synthetic biology market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the synthetic biology market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the synthetic biology market?
  • What is the competitive structure of the global synthetic biology market?
  • Who are the key players/companies in the global synthetic biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Synthetic Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oligonucleotide/Oligo Pools and Synthetic DNA
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Enzymes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cloning Technologies Kits
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Xeno-nucleic Acids
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Chassis Organism
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 NGS Technology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Technology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Genome Editing Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Bioprocessing Technology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Clinical
      • 8.1.2.2 Non-Clinical/Research
    • 8.1.3 Market Forecast
  • 8.2 Non-Healthcare
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Biotech Crops
      • 8.2.2.2 Specialty Chemicals
      • 8.2.2.3 Bio-Fuels
      • 8.2.2.4 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amyris Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Codexis Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GenScript Biotech Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 New England Biolabs
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthego Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Twist Bioscience
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Viridos Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Synthetic Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Synthetic Biology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Synthetic Biology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Synthetic Biology Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Synthetic Biology Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Synthetic Biology Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Synthetic Biology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Synthetic Biology (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Synthetic Biology (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Synthetic Biology (Cloning Technologies Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Synthetic Biology (Cloning Technologies Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Synthetic Biology (Xeno-nucleic Acids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Synthetic Biology (Xeno-nucleic Acids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Synthetic Biology (Chassis Organism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Synthetic Biology (Chassis Organism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Synthetic Biology (NGS Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Synthetic Biology (NGS Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Synthetic Biology (PCR Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Synthetic Biology (PCR Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Synthetic Biology (Genome Editing Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Synthetic Biology (Genome Editing Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Synthetic Biology (Bioprocessing Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Synthetic Biology (Bioprocessing Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Synthetic Biology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Synthetic Biology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Synthetic Biology (Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Synthetic Biology (Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Synthetic Biology (Non-Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Synthetic Biology (Non-Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Synthetic Biology Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Synthetic Biology Industry: SWOT Analysis
  • Figure 82: Global: Synthetic Biology Industry: Value Chain Analysis
  • Figure 83: Global: Synthetic Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Synthetic Biology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Synthetic Biology Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Synthetic Biology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Synthetic Biology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Synthetic Biology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Synthetic Biology Market: Competitive Structure
  • Table 7: Global: Synthetic Biology Market: Key Players